Results 11 to 20 of about 1,067,356 (214)

Global computational alignment of tumor and cell line transcriptional profiles

open access: yesNature Communications, 2021
The determination of whether cancer cell lines recapitulate the molecular features of corresponding patient tumours remains essential for the selection of appropriate cell line models for preclinical studies.
Allison Warren   +8 more
doaj   +1 more source

5-Azacytidine Enhancing Expression of E-cadherin in Adenocarcinoma Cell Line

open access: yesArchives of Advances in Biosciences, 2023
Introduction: In this study, we assessed the expression of E-cadherin in HT29 cell line treated with 5-Azacytidine and colorectal cancer patient in an Iranian population. E-cadherin expression promotes metastasis and prognosis of colorectal cancer (CRC).
Sanaz Savabkar   +4 more
doaj   +1 more source

Establishment and Characterization of A Human Lung Adenocarcinoma Cell Line, 
Ch-Huang-1

open access: yesChinese Journal of Lung Cancer, 2012
Background and objective Lung cancer is a major worldwide health problem. The aim of this study is to establish a novel Chinese human lung adenocarcinoma cell line and examine its biological characteristics.
Bailing LI   +6 more
doaj   +1 more source

Progenitor cell line (hPheo1) derived from a human pheochromocytoma tumor. [PDF]

open access: yesPLoS ONE, 2013
Pheochromocytomas are rare tumors generally arising in the medullary region of the adrenal gland. These tumors release excessive epinephrine and norepinephrine resulting in hypertension and cardiovascular crises for which surgery is the only definitive ...
Hans K Ghayee   +17 more
doaj   +1 more source

Disconnected circadian and cell cycles in a tumor-driven cell line

open access: yesCommunicative & Integrative Biology, 2010
Cell division occurs at a specific time of day in numerous species, suggesting that the circadian and cell cycles are coupled in vivo. By measuring the cell cycle rhythm in real-time, we recently showed that the circadian and cell cycles are not coupled ...
Julie S. Pendergast   +4 more
doaj   +1 more source

In Model, In Vitro and In Vivo Killing Efficacy of Antitumor Peptide RDP22 on MUG-Mel2, a Patient Derived Cell Line of an Aggressive Melanoma Metastasis

open access: yesBiomedicines, 2022
The host defense derived peptide was assessed in different model systems with increasing complexity employing the highly aggressive NRAS mutated melanoma metastases cell line MUG-Mel2.
Maximiliane Wußmann   +9 more
doaj   +1 more source

Storage conditions and passages alter IL-6 secretion in C26 adenocarcinoma cell lines

open access: yesMethodsX, 2015
The C26 adenocarcinoma tumor line is frequently used to establish peripheral tumors in mice for the study of cancer cachexia and cancer-related fatigue. Recently, we have noticed a progressive decline in the effects of tumor growth on our biological and ...
Diana M. Norden   +3 more
doaj   +1 more source

Transferrin-Decorated PLGA Nanoparticles Loaded with an Organoselenium Compound as an Innovative Approach to Sensitize MDR Tumor Cells: An In Vitro Study Using 2D and 3D Cell Models

open access: yesNanomaterials, 2023
Multidrug resistance (MDR) is the main challenge in cancer treatment. In this sense, we designed transferrin (Tf)-conjugated PLGA nanoparticles (NPs) containing an organoselenium compound as an alternative to enhance the efficacy of cancer therapy and ...
Letícia Bueno Macedo   +8 more
doaj   +1 more source

Ablative and Immunostimulatory Effects of Histotripsy Ablation in a Murine Osteosarcoma Model

open access: yesBiomedicines, 2023
Background: Osteosarcoma (OS) is the most frequently occurring malignant bone tumor in humans, primarily affecting children and adolescents. Significant advancements in treatment options for OS have not occurred in the last several decades, and the ...
Alayna N. Hay   +10 more
doaj   +1 more source

A patient‐derived xenograft and a cell line derived from it form a useful preclinical model for small bowel adenocarcinoma

open access: yesCancer Medicine, 2020
Basic and clinical studies on small bowel adenocarcinoma (SBA) are limited due to the rare nature of this cancer. We established a patient‐derived xenograft (PDX) model from the tumor tissue of an advanced SBA patient with liver and peritoneal metastasis,
Tomoki Yamano   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy